Adamis sends letter to stockholders to address jerald a. hammann's costly, distracting and misguided campaign

San diego--(business wire)--adamis pharmaceuticals corporation (nasdaq: admp) today issued the below letter to stockholders. *** july 1, 2021 dear stockholders, the board of directors (the "board") appreciates your continued investment in adamis pharmaceuticals corporation ("adamis" or the "company" or “we”). the board also appreciates the feedback that many stockholders have provided in recent weeks. as we work to position adamis for long-term success, please trust that this input will be care
ADMP Ratings Summary
ADMP Quant Ranking